Navigation Links
Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative
Date:1/10/2012

VIENNA, Austria, January 10, 2012 /PRNewswire/ --

Stem cell-enriched autologous fat enables sustainable breast augmentation with autologous tissue

It was in all the media: For years a French company has been selling defective silicone implants that often rupture and may cause cancer. More than 100,000 women worldwide must now choose between having their implants removed as a precaution or carrying a "time bomb" in their bodies. Stem cell breast augmentation offers an innovative, safe alternative to silicone implants.

"Autologous fat tissue is better tolerated than silicone and is ideal for scarless, completely natural breast augmentation or breast reconstruction after removal of silicone implants or tumors," says DDr. Karl-Georg Heinrich, Vienna-based esthetic and regenerative stem cell therapy expert. His Clinic DDr. Heinrich® has been granting the wishes of patients worldwide for a fuller décolletage without silicone and scars since 2007.

Like all other approved silicone implants, the defective French implants were also CE certified. The defects of these implants remained hidden. But even the best silicone implants represent only a temporary breast augmentation solution. Hence cosmetic surgeons who use silicone implants recommend implant replacements every ten years for all patients.

With stem cell breast augmentation, however, sustainable breast augmentation is generally achievable with just one intervention under local anesthesia. The autologous fat used for breast augmentation is gently liposuctioned with patented microcannulas, enriched with autologous stem cells, and then injected in the breast with fine injection needles.

Along with breast augmentation and stem cell facelifts, stem cell-enriched autologous fat is used in the Clinic DDr. Heinrich® for body shaping (buttocks, hips, upper thighs, calves) as well as dent correction and skin rejuvenation.

Further information: http://ddrheinrich.com/stem-cell-breast-augmentation

Contact:
Clinic DDr. Heinrich®
Contact: Herfried Wagner
E-mail: info@ddrheinrich.com
Web: http://ddrheinrich.com/
Phone: +43-(0)1-532-18 01



'/>"/>
SOURCE Clinic DDr. Heinrich
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Microban Medical Silver Antimicrobial Technologies for HCR Silicone Achieve 5 Log Reductions in Bacteria Growth and Prevent Biofilm Formation
2. Saint-Gobain Introduces Next Generation Silicone Tubing
3. Polymer Science Releases New Silicone Gel Adhesive Products for MD&M West
4. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
5. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
6. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
9. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
10. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
11. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... China , Feb. 4, 2016 Beike ... and various medical institutions attended a ceremony in late ... integrative, personalized cell therapy in 2016. ... "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" was ... Regional Cell Production Center, both subsidiaries of Beike Biotechnology ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. 4, ... and the "Company"), a biopharmaceutical company focused on the development ... will present at the 18 th Annual BIO ... at 10:00 a.m. EST in New York, NY ... and CEO, will provide an update on the ongoing clinical ...
(Date:2/4/2016)... Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Conference 2016, to be held February 8-9, 2016, at ... 2016 Disruptive Growth & Healthcare Conference, taking place in ... 2016. James Sapirstein , Chief Executive Officer ...
(Date:2/4/2016)... BEIJING , Feb. 4, 2016 Sinovac ... ), a leading provider of biopharmaceutical products in ... committee of its board of directors received on February ... 3, 2016, from a consortium comprised of PKU V-Ming ... Sinobioway Biomedicine Co., Ltd., CICC Qianhai Development ( ...
Breaking Biology Technology:
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
(Date:1/22/2016)... DUBLIN , January 22, 2016 ... has announced the addition of the  ... to their offering. --> ... of the  "Global Behavioral Biometric Market ... --> Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ...
Breaking Biology News(10 mins):